- Lois et règlements
- eservices
-
Media Center
Hotline for Health Services for Displaced Lebanese 1787Hotline for the Patient Admission to Hospitals 01/832700COVID-19 Vaccine Registration Form covax.moph.gov.lbMoPH Hotline 1214
Are you a new member? Sign up now
close
SYNAGIS - 100mg/ml - 1x1ml
| ATC | B/G | Ingredients | code | Registration Nb | brand_name | Dosage | Presentation | Form | Route | Agent | Laboratory | man_country | Price | Pharmacist Margin | Startum | Responsible Party Name | Responsible Party Country | Exch_date | %SUBSIDY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| J06BD01 | BioTech | Palivizumab - 100mg/ml | 11750 | 104021/1 | SYNAGIS | 100mg/ml | 1x1ml | Injectable solution | IM | Omnipharma | Boehringer Ingelheim Pharma GmbH & Co KG | Germany | 57,429,464 L.L | 10.71 | E1 | AstraZeneca AB | Sweden | 2/5/2024 | 0 |